BC
DRNA
Birchview Capital’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,000
| Closed | -$373K | – | 66 |
|
|
2021
Q2 | $373K | Hold |
10,000
| – | – | 0.22% | 51 |
|
|
2021
Q1 | $256K | Hold |
10,000
| – | – | 0.15% | 50 |
|
|
2020
Q4 | $220K | Hold |
10,000
| – | – | 0.13% | 46 |
|
|
2020
Q3 | $180K | Hold |
10,000
| – | – | 0.12% | 48 |
|
|
2020
Q2 | $254K | Hold |
10,000
| – | – | 0.15% | 49 |
|
|
2020
Q1 | $184K | Hold |
10,000
| – | – | 0.16% | 42 |
|
|
2019
Q4 | $220K | Sell |
10,000
-30,000
| -75% | -$660K | 0.16% | 46 |
|
|
2019
Q3 | $574K | Sell |
40,000
-5,000
| -11% | -$71.8K | 0.38% | 25 |
|
|
2019
Q2 | $709K | Hold |
45,000
| – | – | 0.43% | 24 |
|
|
2019
Q1 | $659K | Hold |
45,000
| – | – | 0.41% | 23 |
|
|
2018
Q4 | $481K | Hold |
45,000
| – | – | 0.46% | 27 |
|
|
2018
Q3 | $687K | Hold |
45,000
| – | – | 0.44% | 24 |
|
|
2018
Q2 | $551K | Hold |
45,000
| – | – | 0.37% | 29 |
|
|
2018
Q1 | $430K | Hold |
45,000
| – | – | 0.28% | 32 |
|
|
2017
Q4 | $406K | Hold |
45,000
| – | – | 0.24% | 27 |
|
|
2017
Q3 | $259K | Buy |
45,000
+25,000
| +125% | +$144K | 0.13% | 31 |
|
|
2017
Q2 | $63K | Buy |
+20,000
| New | +$63K | 0.03% | 40 |
|